+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Lung Cancer Surgery - Global Strategic Business Report

  • PDF Icon

    Report

  • 279 Pages
  • September 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4805581
The global market for Lung Cancer Surgery was estimated at US$6.2 Billion in 2023 and is projected to reach US$8.3 Billion by 2030, growing at a CAGR of 4.2% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Lung Cancer Surgery Market - Key Trends & Drivers Summarized

Why Is Lung Cancer Surgery a Critical Component of Cancer Treatment Today?

Lung cancer remains one of the most prevalent and deadly cancers worldwide, making effective treatment modalities like surgery crucial in the fight against this disease. Surgery for lung cancer involves the removal of the tumor and surrounding lung tissue where cancer cells may have spread. This approach is generally most effective in the early stages of lung cancer, specifically non-small cell lung cancer (NSCLC), where the tumor is localized and operable. Advances in surgical techniques, including minimally invasive procedures such as video-assisted thoracic surgery (VATS) and robot-assisted surgery, have significantly improved outcomes for patients. These techniques reduce surgical trauma and recovery time, decrease the risk of complications, and can improve the quality of life post-surgery compared to traditional open surgery. As detection methods improve and more lung cancers are diagnosed at an operable stage, the role of surgery in treatment regimens continues to expand.

How Are Technological Advances Transforming Lung Cancer Surgery?

The landscape of lung cancer surgery has been transformed by technological advancements that allow for more precise and less invasive procedures. Innovations such as robotic surgery provide surgeons with enhanced dexterity and control, enabling them to perform complex dissections and remove tumors with high precision while preserving healthy tissue. Furthermore, intraoperative imaging technologies like real-time CT scans and fluorescence imaging have improved the accuracy of tumor localization and the assessment of resection margins, ensuring that more of the cancerous tissue is removed during the initial surgery. These advancements not only increase the success rate of surgical interventions but also minimize the physical impact on patients, leading to faster recovery times and less postoperative discomfort.

What Impact Do Early Detection and Personalized Treatment Have on Lung Cancer Surgery Outcomes?

Early detection and personalized treatment approaches are significantly influencing outcomes in lung cancer surgery. The development of low-dose CT screening for high-risk individuals has led to earlier diagnosis of lung cancer, often at a stage when surgical resection is possible and more likely to be curative. Personalized medicine, which involves genetic profiling of tumors to understand their unique characteristics, has also made strides in determining which patients are good candidates for surgery and how they might best respond to additional treatments such as chemotherapy or targeted therapy. This tailored approach helps in strategizing treatment plans that maximize the efficacy of surgery and minimize unnecessary treatments, thereby improving overall patient survival and quality of life.

Growth in the Lung Cancer Surgery Market Is Driven by Several Factors

The growth in the lung cancer surgery market is driven by several factors, encompassing technological advancements, improved detection methods, and an increased emphasis on personalized medicine. Technological innovations in surgical techniques, including minimally invasive and robotic-assisted surgeries, have broadened the range of operable cases and improved patient outcomes, making surgery a more viable option for many patients. Enhanced screening programs have also played a critical role, as they increase the number of early-stage cancers identified, where surgical intervention can be most beneficial. Additionally, as understanding of the genetic basis of lung cancer improves, personalized surgical treatments are becoming more prevalent, allowing for more targeted and effective interventions. These developments, combined with a growing awareness of lung cancer risks and prevention, continue to drive the demand for surgical solutions in the treatment of lung cancer, reflecting a dynamic and evolving marketplace.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Thoracotomy Procedure segment, which is expected to reach US$5.8 Billion by 2030 with a CAGR of a 4.1%. The Minimally Invasive Surgery segment is also set to grow at 4.6% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $1.7 Billion in 2023, and China, forecasted to grow at an impressive 6.5% CAGR to reach $1.8 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Lung Cancer Surgery Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Lung Cancer Surgery Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Lung Cancer Surgery Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Abbott Molecular, Inc., AbbVie, Inc., Accuray, Inc., and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 111 Featured):

  • Abbott Molecular, Inc.
  • AbbVie, Inc.
  • Accuray, Inc.
  • Ackermann Instrumente GmbH
  • AngioDynamics, Inc.
  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Daiichi Sankyo Co., Ltd.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Lung Cancer Surgery - Global Key Competitors Percentage Market Share in 2024 (E)
  • Global Economic Update
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Lung Cancer Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Thoracotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Thoracotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Thoracotomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Surgical Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Surgical Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Surgical Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Monitoring & Visualizing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for Monitoring & Visualizing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 12: World 16-Year Perspective for Monitoring & Visualizing Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 13: World Lung Cancer Surgery Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 14: World Recent Past, Current & Future Analysis for Minimally Invasive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Minimally Invasive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Minimally Invasive Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Endosurgical Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 18: World Historic Review for Endosurgical Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 19: World 16-Year Perspective for Endosurgical Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 20: USA Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 21: USA Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 22: USA 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
  • Table 23: USA Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 24: USA Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 25: USA 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
CANADA
  • Table 26: Canada Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: Canada Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 28: Canada 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
  • Table 29: Canada Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 30: Canada Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 31: Canada 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
JAPAN
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 32: Japan Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: Japan Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 34: Japan 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
  • Table 35: Japan Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 36: Japan Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 37: Japan 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
CHINA
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 38: China Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: China Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 40: China 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
  • Table 41: China Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 42: China Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 43: China 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
EUROPE
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 44: Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 45: Europe Historic Review for Lung Cancer Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 46: Europe 16-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 47: Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 48: Europe Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 49: Europe 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: Europe Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 52: Europe 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
FRANCE
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 53: France Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 54: France Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 55: France 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
  • Table 56: France Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: France Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 58: France 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
GERMANY
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 59: Germany Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 60: Germany Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 61: Germany 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
  • Table 62: Germany Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 63: Germany Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 64: Germany 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
ITALY
  • Table 65: Italy Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 66: Italy Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 67: Italy 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
  • Table 68: Italy Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 69: Italy Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 70: Italy 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 71: UK Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 72: UK Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 73: UK 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
  • Table 74: UK Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 75: UK Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 76: UK 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
SPAIN
  • Table 77: Spain Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 78: Spain Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 79: Spain 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
  • Table 80: Spain Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 81: Spain Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 82: Spain 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
RUSSIA
  • Table 83: Russia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 84: Russia Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 85: Russia 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
  • Table 86: Russia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 87: Russia Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 88: Russia 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 89: Rest of Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 90: Rest of Europe Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 91: Rest of Europe 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 93: Rest of Europe Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 94: Rest of Europe 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 95: Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 96: Asia-Pacific Historic Review for Lung Cancer Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 97: Asia-Pacific 16-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 99: Asia-Pacific Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 100: Asia-Pacific 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 102: Asia-Pacific Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 103: Asia-Pacific 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
AUSTRALIA
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Molecular, Inc.
  • AbbVie, Inc.
  • Accuray, Inc.
  • Ackermann Instrumente GmbH
  • AngioDynamics, Inc.
  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Daiichi Sankyo Co., Ltd.

Table Information